- Oct 3, 2018
- 3,601
| TYPE | Infrastructure |
| BUILDER | Turkiye |
| CLIENT | Turkiye |
| SITE LOCATION | Turkiye |
| SECTOR | Healthcare |
| PROJECT NAME | National Health and Social Protection Program |
| PROJECT COST | 3,900,000,000.00 |
| COMPLETION DATE | 31/05/2026 |
| PROJECT INFORMATION | Break Down National Health Service (hospitals, rural clinics, vaccination campaigns): ₺2.2 billion Public health insurance subsidies and pharmaceutical assistance: ₺1.1 billion Family welfare, child nutrition, and elderly care programs: ₺0.6 billion This program establishes a comprehensive reinforcement of Türkiye’s public health architecture, combining direct investment in healthcare delivery with targeted social protection measures that expand access and financial security. The initiative is grounded in the principle that healthcare is a core public service and a stabilizing force in both social cohesion and economic productivity. The allocation is structured to address systemic capacity constraints in hospitals and rural clinics, strengthen preventative care through nationwide vaccination campaigns, and reduce the financial burden of healthcare costs on low- and middle-income households. By integrating service delivery with insurance and pharmaceutical support, the program aims to ensure universal access without compromising fiscal sustainability. A significant portion of the allocation will be directed toward the modernization and expansion of public hospitals, with emphasis on emergency care, maternal and child health services, and high-demand specialties such as oncology and cardiology. Investments will include upgrading medical equipment, expanding intensive care capacity, and rehabilitating aging facilities to meet contemporary safety and quality standards. Hospital projects will prioritize regional balance, ensuring that secondary and tertiary care facilities outside major metropolitan centers receive adequate resources. Digital health infrastructure, including electronic medical records and inter-hospital coordination systems, will be expanded to improve efficiency and continuity of care. Recognizing the persistent disparities between urban and rural healthcare access, dedicated funding will support the construction and staffing of rural clinics and family health centers. These facilities will serve as the first point of contact for preventative care, chronic disease management, and basic diagnostics. Mobile health units will supplement fixed clinics in geographically isolated areas, ensuring coverage for populations with limited transportation access. Staffing incentives, including housing and salary supplements, will be introduced to attract medical professionals to underserved regions. Preventative healthcare forms a central pillar of the program, with expanded vaccination campaigns targeting both routine immunizations and emerging public health risks. National coordination will ensure vaccine procurement, cold-chain logistics, and equitable distribution across provinces. Public health outreach initiatives will accompany vaccination efforts, emphasizing health literacy, early screening, and disease prevention. These campaigns will be designed in cooperation with local authorities and community leaders to maximize trust and participation. This component will provide targeted subsidies for public health insurance premiums, focusing on low-income households, informal sector workers, and vulnerable populations. By reducing out-of-pocket costs, the program seeks to prevent delayed care and catastrophic health expenditures. Eligibility criteria will be clearly defined and periodically reviewed to ensure fiscal efficiency and alignment with social protection objectives. Coordination with SGK systems will streamline enrollment and benefit delivery. Funding will support pharmaceutical assistance programs that reduce the cost of essential medications, particularly for chronic conditions such as diabetes, cardiovascular disease, and respiratory illnesses. Negotiated procurement and bulk purchasing mechanisms will be employed to contain costs while ensuring consistent supply. Domestic pharmaceutical production will be incentivized where feasible, strengthening supply chain resilience and reducing exposure to external shocks. Prescription monitoring systems will be enhanced to ensure rational drug use and minimize waste. The program will be administered through the Ministry of Health in close coordination with the Social Security Institution. Transparent procurement processes, independent audits, and performance-based evaluations will ensure accountability and cost control. Implementation will follow a phased approach over four years, allowing infrastructure investments to proceed alongside immediate social protection measures. Annual reporting to Parliament will provide oversight and enable policy adjustments based on public health outcomes. Upon completion, the program is expected to deliver: * Expanded and modernized public healthcare infrastructure * Improved access to primary care in rural and underserved areas * Higher vaccination coverage and stronger preventative health capacity * Reduced financial barriers to healthcare and essential medicines This investment reinforces the public health system as a cornerstone of national well-being, ensuring that healthcare remains accessible, equitable, and resilient in the face of demographic and epidemiological challenges. |
